I was scrolling through TikTok a couple of weeks back, when I suddenly came across a video that had me instantly intrigued.

Patients hospitalized with pleural infection reported better health and less pain 2 months after receiving intrapleural enzyme therapy vs. video-assisted thoracoscopic surgery, according to study ...

Tividenofusp alfa is a first-in-class brain-penetrant enzyme therapy designed to overcome a key limitation of current treatments, which do not reach the brain and fail to address neurological ...

According to SNS Insider, The Enzyme Replacement Therapy Market was estimated at USD 11.27 billion in 2024 and is expected to reach USD 21.70 billion by 2032, at a CAGR of 8.59% during the ...

Primary Source New England Journal of Medicine Source Reference: Cohen J, et al "In utero enzyme-replacement therapy for infantile-onset Pompe's disease" N Engl J Med 2022; DOI: 10.1056/NEJMoa2200587.

INZ-701 is a potential first-in-class, subcutaneous enzyme replacement therapy that is being developed for infants, pediatric and adult patients with ENPP1 Deficiency across a continuum of phenotypes.

Several gene therapies are in development for monogenic lysosomal storage diseases, characterized by an abnormal build-up of various toxic materials in the body’s cells as a result of enzyme ...

Then, on March 24, 2021, maternal-fetal medicine specialists at the Ottawa Hospital delivered the first dose of the enzyme therapy, injecting it into the umbilical vein to reach the fetus.

Immunomodulation and Enzyme Therapy for Improved Efficacy Concomitant administration of an immunosuppressive agent with pegloticase can improve the response rate in patients with uncontrolled gout.

For years, standard Pompe treatment was a Sanofi enzyme replacement therapy called Lumizyme (marketed in Europe as Myozyme), a product that topped €1 billion (about $1.05 billion) in revenue ...

More information: Hemanth R. Nelvagal et al, Cross-species efficacy of enzyme replacement therapy for CLN1 disease in mice and sheep, Journal of Clinical Investigation (2022). DOI: 10.1172/JCI163107 ...

Beyond Pompe Ayla received six prenatal enzyme replacement treatments at The Ottawa Hospital and was born at term. She is now receiving postnatal enzyme therapy at CHEO, a pediatric hospital and ...